Back
Catalyst Pharmaceuticals Vs. Onto Innovation Industry Stock Comparison
Buy
55
CPRX
Catalyst Pharmaceuticals
Last Price:
20.24
Seasonality Move:
-5.57%
Buy
62
ONTO
Onto Innovation
Last Price:
213.23
Seasonality Move:
9.08%
Buy
55
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $20.24. The Score for CPRX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
62
Onto Innovation (ONTO)
is a Buy
Is Onto Innovation a Buy, Sell or Hold?
- The current Onto Innovation [ONTO] share price is $213.22. The Score for ONTO is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- ONTO is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $20.24
The current trend is moderately bullish and CPRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
ONTO Stock Price Chart
What is Onto Innovation's stock price today?
-
The Onto Innovation share price today is $213.22
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ONTO is experiencing slight buying pressure.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.88 | Buy |
| Relative Strength Index (14 RSI): | 63.35 | Buy |
| Chaikin Money Flow: | 416183 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (17.2 - 20.54) | Buy |
| Bollinger Bands (100): | (14.88 - 18.26) | Buy |
ONTO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.44 | Buy |
| Relative Strength Index (14 RSI): | 56.33 | Buy |
| Chaikin Money Flow: | 131728 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (177.29 - 213.09) | Buy |
| Bollinger Bands (100): | (187.69 - 226.69) | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 20.4 | Sell |
| 20-day SMA: | 19.32 | Buy |
| 50-day SMA: | 17.53 | Buy |
| 200-day SMA: | 15.76 | Buy |
| 8-day EMA: | 20.21 | Buy |
| 20-day EMA: | 19.48 | Buy |
| 50-day EMA: | 18.11 | Buy |
| 200-day EMA: | 16.06 | Buy |
ONTO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 210.58 | Buy |
| 20-day SMA: | 199.47 | Buy |
| 50-day SMA: | 206.25 | Buy |
| 200-day SMA: | 184.69 | Buy |
| 8-day EMA: | 209.39 | Buy |
| 20-day EMA: | 204.71 | Buy |
| 50-day EMA: | 204.39 | Buy |
| 200-day EMA: | 184.44 | Buy |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.10 per share, an increase this year of $0.05 per share, and an increase next year of $0.20 per share.
Onto Innovation Earnings Growth & ONTO Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.37 per share, an increase next quarter of $0.45 per share, an increase this year of $1.57 per share, and an increase next year of $1.33 per share.
Catalyst Pharmaceuticals Technical Analysis
| Aug 19 | Aug 20 | Aug 21 | Aug 22 | Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 19 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Onto Innovation Technical Analysis
| Aug 19 | Aug 20 | Aug 21 | Aug 22 | Aug 23 | Aug 26 | Aug 27 | Aug 28 | Aug 29 | Aug 30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug | ||||||||||
| 19 | 20 | 21 | 22 | 23 | 26 | 27 | 28 | 29 | 30 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||